Effect of baseline characteristics on mortality in the SURVIVE trial comparing levosimendan and dobutamine in acute heart failure: sub-analysis of the Finnish patients

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Acute heart failure Acute heart failure (management) HFA Premium Access HEART FAILURE 2016

ESC 365 is supported by

ESC 365 is supported by